ANGO - ANGO Stock Drops 16% Following $46 Million USD Eximo Acquisition

ANGO stock is down 16% today after MedDev company AngioDynamics Inc (NSADAQ:ANGO) agreed to acquire Eximo Medical for $46 million USD.

The New York medical devices company has announced that it will acquire Israeli startup Eximo Medical Ltd, which develops a laser technology catheter device used for the treatment of occlusive peripheral arterial disease (PAD). The deal will see AngioDynamics pay $46 million USD upfront with an additional $20 million USD contingency depending on achieving certain milestones. Eximo’s technology was clinically tested in Poland and is already being used on patients in the US; however, ANGO ...